Home › Diffuse Large B-Cell Lymphoma › Iowa › Cedar Rapids
Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Cedar Rapids, IA
9 pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Cedar Rapids (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Nagre-recruitPhase 2
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Nagre-recruitPhase 1/2
- University of Iowa Hospitals and Clinics, Iowa City · 25 mi ang layo
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Nagre-recruitPhase 2
- University of Iowa-Holden Comprehensive Cancer Center ( Site 0139), Iowa City · 25 mi ang layo
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Nagre-recruitPhase 1
- University of Iowa, Iowa City · 25 mi ang layo
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Nagre-recruitPhase 1/2
- University of Iowa-Holden Comprehensive Cancer Center ( Site 1017), Iowa City · 25 mi ang layo
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Nagre-recruitPhase 1/2
- University of Iowa, Iowa City · 25 mi ang layo
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Nagre-recruitPhase 3
- University of Iowa, Iowa City · 25 mi ang layo
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Nagre-recruitPhase 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi ang layo
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Nagre-recruitPhase 2
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod
- New York City, NY21 pag-aaral
- Baldwin Park, CA19 pag-aaral
- Chicago, IL18 pag-aaral
- Houston, TX17 pag-aaral
- Los Angeles, CA17 pag-aaral
- Milwaukee, WI16 pag-aaral
- Boston, MA16 pag-aaral
- Philadelphia, PA15 pag-aaral
- Portland, OR15 pag-aaral
- Durham, NC14 pag-aaral
- Nashville, TN14 pag-aaral
- Dallas, TX13 pag-aaral
Iba pang pag-aaral sa Cedar Rapids
- Non-Small Cell Lung Cancer20 pag-aaral
- Kanser sa Suso17 pag-aaral
- Acute Myeloid Leukemia16 pag-aaral
- Kanser (lahat ng uri)16 pag-aaral
- Multiple Myeloma15 pag-aaral
- Kanser sa Baga14 pag-aaral
- Colorectal Cancer13 pag-aaral
- Kanser sa Prostate12 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg12 pag-aaral
- Melanoma10 pag-aaral
- Stroke10 pag-aaral
- Kanser ng Endometrium10 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.